– USA, CA – GlobalLogic Inc., a leader in digital product engineering, today announced the appointment of Stephen Oesterle and Normand Legault to its board of directors.
“I am very pleased to have both Stephen and Normand on the GlobalLogic Board of Directors, they join at a time of pivotal growth for the company,” said Shashank Samant, CEO, GlobalLogic. “As we expand our offerings and move into new verticals, it’s important to have diverse perspectives, and fresh ideas from advisors as the company continues to grow globally. These are two savvy executives who have the specific skill sets we need to guide us, as we progress into the future.”
In every industry, brands across the globe are transforming their businesses and products using digital technology, with the aim to better engage their customers, and create new revenue streams. GlobalLogic helps enterprises navigate these transitions with Advisory, Strategic Design and Complex Engineering services. The new members of the board will direct GlobalLogic’s strategy and execution with a focus on growth, and the continued evolution of the company and its offerings to address emerging customer requirements and new market opportunities.
About tephen Oesterle
Stephen Oesterle is currently a Venture Partner at New Enterprise Associates, as well as a senior advisor to EQT Partners and Temasek Holdings. He serves on the boards of Baxter International and Reva Medical along with two biotech startups in Boston. Prior to his board positions, he spent 14 years as a senior vice president of Medicine and Technology at Medtronic plc. He joined the company after a very successful career as a practicing interventional cardiologist and educator. Steve received his undergraduate degree from Harvard, Doctor of Medicine (MD) from Yale University, and post-doctoral fellowships from Harvard Medical School and Stanford University. He developed interventional cardiology programs at Stanford, Georgetown and the Massachusetts General Hospital while serving on the faculties of their respective medical schools. Steve brings a wealth of experience as an operating executive and board member alike.
About Normand Legault
Normand Legault is senior private equity advisor to the CPP Investment Board. He is also President of GPF1 Inc., an advisory and mergers and acquisition consultancy, a professional sports, live entertainment and communications advisory company. In addition, he serves on the boards of Dorna Sports, a Madrid-based sports management, marketing and media company and Aéroports de Montréal, a private, not-for-profit corporation responsible for the operation and management of the of Montreal’s largest international airports. A seasoned operating executive, prior to his board positions, Normand was CEO and Chairman of Solotech, Inc., an innovative provider of technological solutions in audio, video, lighting and rigging, for professional sports venues, broadcast, cultural venues, boardrooms and classrooms. Normand earned his undergraduate degree in Business Administration from Université de Sherbrooke in Quèbec, and completed the Owner/President Management (OPM) program at Harvard Business School.
GlobalLogic is a leader in digital product engineering. We help our clients design and build innovative products, platforms, and digital experiences for the modern world. By integrating strategic design, complex engineering, and vertical industry expertise — we help our clients imagine what’s possible, and accelerate their transition into tomorrow’s digital businesses. Headquartered in Silicon Valley, GlobalLogic operates design studios and engineering centers around the world, extending our deep expertise to customers in the communications, automotive, healthcare, technology, media and entertainment, manufacturing, and semiconductor industries.
For more information : https://www.globallogic.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
Comments are closed.